作者：
Sam,Nightingale [1]
;
Benedict D,Michael [2]
;
Martin,Fisher [3]
;
Alan,Winston [4]
;
Mark,Nelson [5]
;
Steven,Taylor [6]
;
Andrew,Ustianowski [7]
;
Jonathan,Ainsworth [8]
;
Richard,Gilson [9]
;
Lewis,Haddow [9]
;
Edmund,Ong [10]
;
Clifford,Leen [11]
;
Jane,Minton [12]
;
Frank,Post [13]
;
Apostolos,Beloukas [14]
;
Ray,Borrow [15]
;
Munir,Pirmohamed [16]
;
Anna Maria,Geretti [14]
;
Saye,Khoo [16]
;
Tom,Solomon [2]
作者单位：
Institute of Infection and Global Health, University of Liverpool, UK; Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK; Royal Liverpool and Broadgreen University Hospitals NHS Trust, UK. Electronic address: s.nightingale@liv.ac.uk.
[1]
Institute of Infection and Global Health, University of Liverpool, UK; Walton Centre for Neurology and Neurosurgery, Liverpool, UK.
[2]
Brighton and Sussex University Hospitals NHS Trust, UK.
[3]
St Marys' Hospital, Imperial College Heathcare NHS Trust, London, UK.
[4]
St Stephen's AIDS Research Trust and Chelsea and Westminster Hospital NHS Foundation Trust, UK.
[5]
Birmingham Heartlands Hospital, Heart of England NHS Foundation Trust, UK.
[6]
North Manchester General Hospital, Pennine Acute Hospitals NHS Trust, UK.
[7]
North Middlesex University Hospital NHS Trust, UK.
[8]
Research Department of Infection and Population Health, University College London, UK.
[9]
Victoria Royal Infirmary, Newcastle upon Tyne Hospitals NHS Trust, UK.
[10]
Royal Infirmary of Edinburgh, NHS Lothian, UK.
[11]
Leeds General Infirmary, Leeds Teaching Hosptials NHS Trust, UK.
[12]
Kings College Hospital NHS Foundation Trust, London, UK.
[13]
Institute of Infection and Global Health, University of Liverpool, UK.
[14]
Vaccine Evaluation Unit at the Health Protection Agency (HPA) North West, Manchester, UK.
[15]
Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, UK.
[16]
DOI
10.1016/j.cyto.2016.04.004
PMID
27131579
发布时间
2022-01-29
换一批
换一批
